Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study

被引:16
作者
von Gunten, V
Amos, V
Sidler, AL
Beney, J
Troillet, N
Reymond, JP
机构
[1] Cent Inst Valais Hosp, Div Pharm, CH-1950 Sion, Switzerland
[2] Cent Inst Valais Hosp, Div Infect Dis, CH-1950 Sion, Switzerland
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 02期
关键词
antibiotics; cost; cost analysis; oral administration; practice guidelines; pharmaceutical services; switch; Switzerland;
D O I
10.1023/A:1023240829761
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The cost of antibiotics in hospitals may be reduced by streamlining, and, particularly, by early switching from the intravenous (i.v.) to the oral route of administration. The aim of the study was to evaluate the feasibility and impact of guidelines for switching, reinforced by pharmacists. Method: Patients admitted to internal medicine wards and treated with i.v. antibiotics for various infections were included for six weeks before (group A) and six weeks after (group B) the intervention. Differences in patient characteristics and their outcomes were sought between the two groups. Results: The 26 patients in group B stayed longer in hospital than the 29 in group A (13.3 vs. 9.7 days; P = 0.05). They also tended to need more time to reach the pre-defined criteria for switching (3.6 vs. 2.4 days; P = 0.09). From that point on, they were switched more rapidly to oral antibiotics (1.5 vs. 3.2 days; P = 0.02), which resulted in a trend toward a lower treatment cost until their discharge (44 vs. 92 euros; P = 0.08). No difference was found between the 2 groups for the duration of the i.v. therapy, or the total in-hospital cost of antibiotics. Conclusion: Pharmacists may help implement and reinforce guidelines for switching to oral antibiotics. The evaluation of such interventions implies the choice of appropriate outcomes and the awareness of confounding factors.
引用
收藏
页码:52 / 55
页数:4
相关论文
共 10 条
[1]  
Bailey TC, 1997, PHARMACOTHERAPY, V17, P277
[2]   The pharmacist's role in promoting optimal antimicrobial use [J].
Dickerson, LM ;
Mainous, AG ;
Carek, PJ .
PHARMACOTHERAPY, 2000, 20 (06) :711-723
[3]   Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion [J].
Martínez, MJ ;
Freire, A ;
Rodriguez, I ;
Bardán, B ;
Castro, I ;
Inaraja, MT ;
Ortega, A ;
Del Campo, V ;
Morano, LE ;
Garcia, JF .
PHARMACY WORLD & SCIENCE, 2000, 22 (02) :53-58
[4]   A framework for effective management of change in clinical practice: dissemination and implementation of clinical practice guidelines [J].
Moulding, NT ;
Silagy, CA ;
Weller, DP .
QUALITY IN HEALTH CARE, 1999, 8 (03) :177-183
[5]  
Ramirez J A, 1996, Pharm Pract Manag Q, V16, P19
[6]   Early switch from intravenous to oral antibiotics and early hospital discharge -: A prospective observational study of 200 consecutive patients with community-acquired pneumonia [J].
Ramirez, JA ;
Vargas, S ;
Ritter, GW ;
Brier, ME ;
Wright, A ;
Smith, S ;
Newman, D ;
Burke, J ;
Mushtaq, M ;
Huang, A .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (20) :2449-2454
[7]   Early switch from intravenous to oral antibiotics:: guidelines and implementation in a large teaching hospital [J].
Sevinç, F ;
Prins, JM ;
Koopmans, RP ;
Langendijk, PNJ ;
Bossuyt, PMM ;
Dankert, J ;
Speelman, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :601-606
[8]  
TILQUIN C, 1989, MESURE NIVEAU SOINS
[9]   Implementing a program for switching from i.v. to oral antimicrobial therapy [J].
Wong-Beringer, A ;
Nguyen, KH ;
Razeghi, J .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (12) :1146-1149
[10]   Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care healthy facility [J].
Zamin, MT ;
Pitre, MM ;
Conly, JM .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (05) :564-570